InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
6
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+3.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Whaley Glenn, Chief Financial Officer. Director active across 1 company, notably Immunic, INC.. Aggregated, 6 reports have been logged. Split: 6 buys · 0 sell. Total volume traded: €65k. Activity tracked since 10 August 2021. The latest transaction was filed on 15 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
5,000 shares@ US$1.7512.3% of flowCommon StockSEC:0001193805-23-000735:0
Ideal exit: 9 Feb 2024 (T+270)
5,000 shares@ US$1.49511.5% of flowCommon StockSEC:0001193805-22-001497:0
Ideal exit: 4 Aug 2023 (T+270)
3,500 shares@ US$3.0450.0060% mcap19.9% of flowCommon StockSEC:0001193805-22-000918:0
Ideal exit: 28 Feb 2023 (T+270)
3,000 shares@ US$5.080.0089% mcap29.5% of flowCommon StockSEC:0001193805-22-000788:0
Ideal exit: 6 Feb 2023 (T+270)
1,500 shares@ US$9.850.0077% mcap25.3% of flowCommon StockSEC:0001193805-21-001163:0
Ideal exit: 7 May 2022 (T+270)
1,500 shares@ US$9.8519.3% of flowCommon StockSEC:0001193805-21-001163
Ideal exit: 7 May 2022 (T+270)
6 of 6 declarations
About Whaley Glenn
Glenn Whaley is the Chief Financial Officer at Immunic, Inc. He oversees the financial operations of the company, including budgeting and risk management. His role is crucial in ensuring the financial health and growth of the company.
